Upper Respiratory Tract Infection (URTI) – A Complete Medical Guide

Overview

A **Upper Respiratory Tract Infection (URTI)** refers to an infection that involves the structures of the nose, sinuses, pharynx, or larynx. The term is often used interchangeably with “common cold,” although a URTI can also include infections such as sinusitis, laryngitis, and acute bronchitis when the infection spreads to the lower airway.

• Who it affects: Almost everyone will experience at least one URTI each year. Children under 5 have the highest incidence (6‑10 episodes per year), while adults average 2‑4 episodes annually.¹
• Prevalence: In the United States, URTIs account for more than 20 million physician visits and 10–15 million missed work or school days each year.²
• Seasonality: Incidence peaks in the fall and winter in temperate climates, correlating with lower humidity and increased indoor crowding.

Symptoms

Symptoms can range from mild and self‑limited to moderately uncomfortable. The typical clinical picture includes:

• Nasopharyngeal congestion or runny nose – Clear, watery discharge that may become thicker and yellow/green after 3–5 days.
• Sore throat – Irritation, scratchy feeling, or pain that worsens with swallowing.
• Cough – Usually dry in the first 2–3 days, becoming productive (phlegm) later.
• Sneezing – Often the first sign, triggered by irritation of nasal mucosa.
• Headache – Usually mild and located around the forehead or sinuses.
• Low‑grade fever – 37.5–38.3 °C (99.5–101 °F) more common in children.
• Fatigue & malaise – General feeling of being unwell.
• Ear fullness or mild ear pain – Due to eustachian tube blockage.
• Hoarseness or loss of voice – When the larynx is involved (laryngitis).

Symptoms usually appear 1–3 days after exposure to the pathogen and resolve within 7–10 days. Persistence beyond 14 days, worsening fever, or new focal symptoms (e.g., severe sinus pain) should prompt further evaluation.

Causes and Risk Factors

Common Causative Agents

• Viruses (≈90% of cases)
  • Rhinoviruses (30‑50%) – the most common
  • Coronaviruses (OC43, 229E, NL63, HKU1)
  • Respiratory syncytial virus (RSV)
  • Influenza A & B
  • Parainfluenza, adenovirus, enterovirus
• Bacteria (≈10% of cases) – usually secondary infections after viral damage.
  • Streptococcus pyogenes (strep throat)
  • Staphylococcus aureus
  • Haemophilus influenzae
  • Moraxella catarrhalis

Risk Factors

• Age: Children have immature immune systems and higher exposure in schools.
• Close contact settings: Daycare, schools, prisons, nursing homes.
• Seasonal factors: Low humidity, cold weather, and indoor crowding.
• Smoking or exposure to secondhand smoke: Impairs mucociliary clearance.
• Immunocompromised states: HIV, chemotherapy, transplant patients.
• Allergic rhinitis or chronic sinus disease: Pre‑existing inflammation predisposes to infection.
• Poor hand hygiene: Facilitates transmission of droplets and fomites.

Diagnosis

URTI is primarily a clinical diagnosis based on history and physical exam. In most cases, no laboratory testing is required. However, certain scenarios warrant additional evaluation.

Clinical Assessment

• History of recent exposure, symptom onset, and progression.
• Physical examination: nasal mucosal erythema, throat erythema/tonsillar exudates, cervical lymphadenopathy, lung auscultation.

When to Order Tests

• Rapid antigen detection test (RADT) for Group A Streptococcus if strep throat is suspected.
• Polymerase chain reaction (PCR) panels for viral pathogens when a patient is high‑risk (e.g., immunocompromised) or when results will change management (e.g., influenza‑specific antivirals).
• Complete blood count (CBC) – may show leukocytosis in bacterial superinfection.
• Sinus imaging (CT) – reserved for suspected complicated sinusitis lasting >10 days with severe pain or orbital involvement.
• Chest X‑ray – only if lower respiratory tract involvement is suspected (e.g., bronchitis, pneumonia).

Treatment Options

General Principles

Because the majority of URTIs are viral, antibiotics are not routinely indicated and can contribute to antimicrobial resistance.³ Symptomatic care and supportive measures are the mainstay of treatment.

Medications

• Analgesics/Antipyretics: Acetaminophen or ibuprofen for fever, headache, or sore throat.
• Decongestants: Oral (pseudoephedrine) or topical (oxymetazoline) for nasal congestion—use ≤3 days to avoid rebound congestion.
• Antihistamines: First‑generation (diphenhydramine) for runny nose or sneezing; second‑generation (loratadine, cetirizine) have fewer sedative effects.
• Cough suppressants: Dextromethorphan for dry cough; expectorants (guaifenesin) for productive cough.
• Topical analgesic lozenges: Containing menthol or benzocaine for throat discomfort.
• Antiviral therapy: Reserved for influenza—oseltamivir or baloxavir if started within 48 h of symptom onset, especially in high‑risk patients.⁴
• Antibiotics: Indicated only for confirmed bacterial infections (e.g., Group A Strep, bacterial sinusitis). Typical regimens include penicillin V or amoxicillin for strep throat.

Lifestyle & Home Remedies

• Increase fluid intake (water, broth, herbal tea) to thin mucus.
• Humidify indoor air (30‑50% relative humidity) to soothe irritated mucosa.
• Rest and limit strenuous activity while symptomatic.
• Salt‑water gargle (½ tsp salt in 240 ml warm water) 2‑3 times daily for sore throat.
• Honey (1 tsp) for cough in patients >1 year old—has modest cough‑relieving effect.⁵

Living with Upper Respiratory Tract Infection (URTI)

Daily Management Tips

• Hydration: Aim for at least 2 L of fluids per day; electrolytes may help if fever is present.
• Nutrition: Light, balanced meals; consider soups rich in protein and vitamins (e.g., chicken noodle soup).
• Sleep: 7–9 hours for adults, more for children; sleep supports immune function.
• Hygiene: Frequent hand washing with soap for ≥20 seconds; use alcohol‑based hand sanitizer when washing isn’t possible.
• Isolation: Stay home while feverish or when symptoms are severe; avoid close contact with vulnerable individuals (elderly, infants, immunocompromised).
• Monitoring: Keep a symptom diary; note any new or worsening signs (e.g., high fever >39 °C, shortness of breath).
• Medication safety: Follow dosing instructions; avoid mixing decongestants with certain antidepressants (MAO inhibitors) without physician guidance.

When to Follow‑up

If symptoms persist beyond 10–14 days, worsen after an initial improvement, or new focal symptoms appear (e.g., severe sinus pain, ear discharge, worsening cough), schedule a medical review.

Prevention

• Vaccination: Annual influenza vaccine; COVID‑19 boosters as recommended; pneumococcal vaccine for high‑risk adults.
• Hand hygiene: Hand washing remains the single most effective preventive measure.⁶
• Respiratory etiquette: Cover mouth/nose with tissue or elbow when coughing/sneezing; dispose of tissues promptly.
• Avoid touching face: Especially eyes, nose, and mouth.
• Environmental controls: Use HEPA filters, maintain indoor humidity 40‑60% during winter, and improve ventilation (open windows or use exhaust fans).
• Limit exposure: During peak cold/flu season, avoid crowded indoor events if you are immunocompromised.
• Smoking cessation: Reduces mucosal inflammation and improves clearance.

Complications

While most URTIs are benign, complications can arise, especially in high‑risk groups.

• Acute bacterial sinusitis – occurs in ~1‑2% of colds; presents with facial pain, purulent nasal discharge, and fever lasting >10 days.
• Otitis media – common in children; ear pain, fever, and hearing loss.
• Acute bacterial pharyngitis – especially Group A Streptococcus; risk of rheumatic fever or post‑streptococcal glomerulonephritis if untreated.
• Bronchitis or lower respiratory tract infection – cough may persist >3 weeks; can progress to pneumonia in elderly or immunocompromised.
• Exacerbation of chronic lung disease – asthma or COPD flare‑ups triggered by viral URTIs.
• Meningitis or encephalitis – rare but severe complications of certain viral infections (e.g., influenza, COVID‑19).

When to Seek Emergency Care

---

**References**

1. Centers for Disease Control and Prevention. Common Cold – Fast Stats. Accessed June 2026.
2. CDC. Burden of Influenza. 2024 update.
3. CDC. Antibiotics in Upper Respiratory Infections. 2023.
4. CDC. Influenza Antiviral Treatment Guidelines. 2024.
5. Cooper R, et al. Honey for cough in children. Cochrane Database Syst Rev. 2021;CD001041.
6. World Health Organization. Hand Hygiene Recommendations. 2020.